Home » The securities firm’s 1 billion rights issue will be listed next week, and pressure on these stocks to lift the ban will increase.

The securities firm’s 1 billion rights issue will be listed next week, and pressure on these stocks to lift the ban will increase.

by admin

Original title: This securities firm is about to list 1 billion allotment shares, and the pressure on these stocks to lift the ban will increase next week

A total of 51 shares in the two cities will usher in the lifting of the ban next week. Based on the closing price on August 20, the total market value of the ban is 102.5 billion yuan, and the market value of the ban has dropped from last week.

From the perspective of the number of banned shares, Hongta Securities’ number of banned shares exceeded 1 billion, ranking first in the number of banned shares released next week. It is worth noting that the market value of this part of the banned shares corresponds to 14.6 billion yuan, and the type of banned shares is the previous company’s Allotment. According to the data, the issue price of Hongta Securities’ rights issue is RMB 7.33 per share, and the current stock price is RMB 13.51. The current stock price is more than 80% premium to the price of the rights issue.

In addition, Jinchuang Group, Jinkai Xinneng, BAIC Blue Valley, NavInfo and other stocks have a large number of shares lifted, each exceeding 300 million shares.

From the perspective of the proportion of lifted shares to the total share capital, Jinchuang Group’s lifted shares accounted for 66% of the total share capital, corresponding to a market value of 5.3 billion yuan, and the type of lifted ban is the additional commitment restricted shares.

In addition, Kangchen Pharmaceutical, Kangtai Medical, Meichang, Blue Shield Optoelectronics and other stocks accounted for more than 40% of the total share capital, ranking in the forefront of the banned shares next week.

See also  Andreas Nygaard and Hedda Østberg Amundsen won the Kobberløpet - KONDIS

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy